Protective effect of lactoferrin on acute acid reflux-induced esophageal mucosal damage

Hepato-Gastroenterology

Volumn 61, Issue 134, 2014, Pages 1595-1600

  Inamori, Masahiko ^a   Togawa, Jun Ichi ^a   Matsumoto, Shuhei ^a   Hara, Koji ^a   Matsuura, Mizue ^a   Iida, Hiroshi ^a   Akimoto, Keiko ^a   Endo, Hiroki ^a   Nonaka, Takashi ^a   Takahashi, Hirokazu ^a   Koide, Tomoko ^a   Shibata, Wataru ^a   Ida, Tomonori ^a   Kusakabe, Akihiko ^a   Nagase, Hajime ^b   Tominaga, Shizuo ^a   Tanaka, Katsuaki ^a   Gotoh, Eiji ^c   Nakajima, Atsushi ^a   Maeda, Shin ^a  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Acid reflux; Acid secretion; Esophageal damage; Gastrin; Lactoferrin

Indexed keywords

GASTRIN; LACTOFERRIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; ENZYME ACTIVITY; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; GASTRIN BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION; ANIMAL; BLOOD; CELL PROTECTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ESOPHAGUS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MUCOSA; PATHOLOGY; SECRETION (PROCESS); STOMACH ACID; STOMACH MUCOSA; WISTAR RAT;

ANIMALS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGUS; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GASTROESOPHAGEAL REFLUX; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LACTOFERRIN; MALE; MUCOUS MEMBRANE; PROTECTIVE AGENTS; RATS, WISTAR;

EID: 84906965429     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13380     Document Type: Article

References (27)

1. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009; 44: 518-34.
2. Inamori M, Togawa J, Nagase H, Abe Y, Umezawa T, Nakajima A, Saito T, Ueno N, Tanaka K, Sekihara H, Kaifu H, Tsuboi H, Kayama H, Tominaga S, Nagura H. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol. 2003; 18:172-6. (Pubitemid 36349864)
3. Brock JH. Lactoferrin-50 years on. Biochem Cell Biol. 2012; 90: 245-51.
4. Groves, ML. The isolation of a red protein from milk. J. Am. Chem. Soc. 1960; 82: 3345-3350.
5. Montreuil J, Tonnelate J, Mullet S. Preparation et proprietes de la lactosiderophiline (lactotransferrine) du lati de femme. Biochim Biophys Acta. 1960; 45: 413-421.
6. Johansson, B. Isolation of an iron-containing red protein from human milk. Acta Chem Scand. 1960; 14: 510-512.
7. Togawa J, Nagase H, Tanaka K, Inamori M, Umezawa T, Nakajima A, Naito M, Sato S, Saito T, Sekihara H. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol. 2002; 283: G187-95. (Pubitemid 34666177)
8. Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol. 2002; 17: 1291-8. (Pubitemid 35356966)
9. Ghosh MN, Schild HO. Continuous recording of acid gastric secretion in the rat. Br J Pharmacol Chemother. 1958; 13: 54-61.
10. Yamauchi K, Toida T, Nishimura S. 13-week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol. 2000; 38: 503-512. (Pubitemid 30319350)
11. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotoriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989; 96: 29-36. (Pubitemid 19046263)
12. Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, Ito E, Suzuki I, Kulkarni AD, Kawajiri A, Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor α production in trinitrobenzen sulphonic acid induced colitis. Gut 1997; 41: 487-493. (Pubitemid 27448780)
13. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protections by tolerance. J Immunol. 1996; 157: 2174-2185. (Pubitemid 126449698)
14. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989; 96: 795-803. (Pubitemid 19057602)
15. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982; 78: 206-209. (Pubitemid 12171880)
16. Hallahan DE, Mauceri HJ Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Heilman S, Kufe DW, Weichselbaum RR. Spatial and temporal control of gene therapy using ionizing radiation. Nature Medicine1995; 1: 786-791.
17. Lopez-Talavera JC, Levitzki A, Martinez M, Gazit A, Esteban R, Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxidase production in cirrhotic rats with portal hypertension and ascites. J Clin Invest 1997; 100: 664-670. (Pubitemid 27340515)
18. Lonnerdal B, Iyar S. Lactoferrin: molecular structure and biological function. Ann Rev Nutr. 1995; 15: 93-110.
19. Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood. 1992; 80: 235-240.
20. He J, Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature. 1995; 373: 721-724.
21. Hutchens TW, Henry JF, Yip TT, Hachey DL, Schanler RJ, Motil KJ, Garza C. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment Paediatr Res. 1991; 29; 243-250.
22. Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hansen LA. Lactoferrin or a fragment thereof inhibits the endotoxin-induced IL-6 release response in human monocytic cells. Paediatr Res. 1996; 40: 257-262. (Pubitemid 26249678)
23. Te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 inhibits secretion of IL-1β, tumor necrosis factor α and IL-6 by human monocytes. Blood. 1990; 76: 1392-1397. (Pubitemid 20342757)
24. Inatomi N, Nagaya H, Takami K, Shino A, Satoh H. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol. 1991; 55: 437-51.
25. Nakamura K, Ozawa Y, Furuta Y, Miyazaki H. Effects of sodium polyacrylate (PANa) on acute esophagitis by gastric Juice in rats. Jpn J Pharmacol. 1982; 32: 445-56. (Pubitemid 12082389)
26. Omura N, Kashiwagi H, Chen G, Yano F, Suzuki Y, Aoki T. Effects of ecabet sodium on experimentally induced reflux esophagitis. J Gastroenterol. 2000; 35: 504-9. (Pubitemid 30468455)
27. Omura N, Kashiwagi H, Chen G, Suzuki Y, Yano F, Aoki T. Establishment of surgically induced chronic acid reflux esophagitis in rats. Scand J Gastroenterol. 1999; 34: 948-53. (Pubitemid 29512861)